SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

CARE revises ratings of Godavari Drugs’ bank facilities

12 Feb 2016 Evaluate

Credit rating agency, Credit Analysis & Research (CARE) has revised rating of Godavari Drugs’ long term bank facilities worth Rs 6 crore to ‘BB+’ from ‘BB’. The rating agency has also revised rating of company’s short term bank facilities worth Rs 15 crore to ‘A4+’ from ‘A4’. The revision in the ratings assigned to the bank facilities of Godavari Drugs (GDL) is on account of significant increase in the total operating income of the company during FY15 (refers to the period April 01 to March 31) backed by increase in focus on direct sales, diversified clientele and improved operating cycle.

The ratings are, however, constrained by decrease in profitability margins during FY15, product concentration risk and presence in highly fragmented industry with many unorganized players.

Godavari Drugs Share Price

130.15 4.05 (3.21%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×